Kytril 1 mg, 2 mg, 3 mg/3 m, 1 mg/1 m TABLET / INJECTION
PDF Leaflet Revision Date: 11 August 2006
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention and treatment of nausea and vomiting.
Dosage (summary)
Adults: 1 mg twice daily or 2 mg once daily for CINV; 1-3 mg IV before chemotherapy.
Onset of Action / Duration
Onset: 30 mins, Duration: 9 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established; use only if benefits outweigh risks.
Key Drug Interactions
- Phenobarbital
- Ketoconazole
Contraindications
- Hypersensitivity to granisetron
- Children under 2 years
Common side effects
- Headache
- Constipation
- Skin rashes
- Allergic reactions
Counselling Points
- Monitor for signs of intestinal obstruction
- Report any allergic reactions
Serious warnings
- May reduce bowel motility
- Max dose: 9 mg/24 hours
Important Disclaimer
The Kytril 1 mg, 2 mg, 3 mg/3 m, 1 mg/1 m TABLET / INJECTION professional information leaflet below is the property of Pharmaco Distribution and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
